Huntington’s disease: undoing the damage
Written by Gary Finnegan | 31 Jul 2012
by Gary Finnegan – World Health Matters (South Korea) – Stem cells could be used to restore neuron function to parts of the brain damaged by Huntington’s disease… read more.
Fertility funding can boost birth rates
Written by Gary Finnegan | 31 Jul 2012
by Gary Finnegan – World Health Matters (Holland) – Higher levels of public reimbursement for fertility treatment can positively influence national birth rates, according to a study by… read more.
Duloxetine relieves chemotherapy-related neuropathy
Written by Lorraine Carolan | 31 Jul 2012
The antidepressant duloxetine (Cymbalta ®) can effectively treat chemotherapy-induced neuropathy in some patients , researchers reported on July 3, 2012 at the American Society of Clinical Oncology Annual… read more.
Dendritic cells protect against acute pancreatitis
Written by Lorraine Carolan | 31 Jul 2012
Researchers identify new therapeutic target for pancreas’ dangerous, sudden swelling and inflammation.
MRSA cases in US academic hospitals double in 5 years
Written by Lorraine Carolan | 31 Jul 2012
Infections caused by methicillin-resistant Staphylococcus aureus (MRSA) doubled at academic medical centers in the U.S. between 2003 and 2008, according to a report published in the August issue… read more.
Laparoscopy reduces the risk of small-bowel obstruction
Written by Lorraine Carolan | 31 Jul 2012
Open surgery appears to be associated with an increased risk of small-bowel obstructions compared to laparoscopic procedures. This is shown by a new study at the Sahlgrenska Academy,… read more.
New guidelines on Parkinson’s and antibacterials
Written by Gary Finnegan | 31 Jul 2012
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The European Medicines Agency has updated its guidelines for pharmaceutical companies developing medicines for Parkinson’s disease.
Green light for use of child vaccine outside EU
Written by Gary Finnegan | 31 Jul 2012
by Gary Finnegan – Emerging uses of EMA Approved Drugs – The European Medicines Agency (EMA) has given its backing to the use of a Hexaxim outside the… read more.
Pazopanib prolongs progression-free survival in patients with advanced soft-tissue Sarcoma
Written by Bruce Sylvester | 31 Jul 2012
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Treatment with pazopanib nearly tripled progression-free survival (PFS), compared with placebo, among patients with metastatic soft-tissue sarcoma… read more.
Hormone-depleting drug appears to have efficacy in localized high-risk prostate tumors
Written by Bruce Sylvester | 31 Jul 2012
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – A hormone-depleting drug approved in 2011 for the treatment of metastatic prostate cancer appears to help eliminate… read more.
Prednisolone reduces sequelae in Bell’s Palsy
Written by Bruce Sylvester | 31 Jul 2012
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
Prednisolone reduces sequelae in Bell's Palsy
Written by Bruce Sylvester | 31 Jul 2012
by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Patients treated for Bell palsy with prednisolone within 72 hours achieved significantly reduced severity of mild to… read more.
Subscribe for our mailing list
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
This website uses cookies to enhance your browsing experience, analyse site traffic, and personalise content. By clicking “Accept” you consent to the use of all cookies. You can manage your preferences or withdraw consent at any time by visiting our cookie settings.
Functional Always active
Preferences
Statistics
Marketing
If you’re a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

